宁嗽化痰汤治疗慢性阻塞性肺疾病急性加重期疗效观察及对血清炎症因子、VEGF 及bFGF 水平的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.14;R563

基金项目:

金华市中医药科学技术研究计划项目(2022KY12)


Observation on Efficacy of Ningsou Huatan Decoction in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Serum Inflammatory Factors,VEGF,and bFGF Levels
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察宁嗽化痰汤治疗慢性阻塞性肺疾病(COPD) 急性加重期的临床疗效及对血清炎症因 子、血管内皮生长因子(VEGF) 及碱性成纤维细胞生长因子(bFGF) 水平的影响。方法:选取2022年1月— 2023年12月期间,在金华市中医医院接受住院治疗的126例COPD急性加重期患者作为研究对象,按随机数字 表法分为对照组与研究组各63例。对照组进行常规西药治疗;研究组在对照组的基础上联合宁嗽化痰汤治疗。 疗程均为2周。比较2组临床疗效,以及治疗前后中医证候评分、肺功能指标[第1秒用力呼气量(FEV1)、用 力肺活量(FVC)、FEV1/FVC比值]、血气分析指标[动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)]、 炎症因子指标[白细胞介素-6(IL-6)、C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)]、VEGF及bFGF水 平。结果:治疗后,研究组总有效率为95.24%(60/63),对照组为79.37%(50/63),2组比较,差异有统计学 意义(P<0.05)。治疗后,2组呼吸不畅、咳嗽、喘息、咳痰评分及总分均较治疗前降低(P<0.05),且研究 组各项评分及总分均低于对照组(P<0.05)。治疗后,2组FEV1、FVC、FEV1/FVC水平均较治疗前升高(P< 0.05),且研究组3项指标水平均高于对照组(P<0.05)。治疗后,2组PaO2水平均较治疗前升高(P<0.05), 且研究组高于对照组(P<0.05);2 组PaCO2 水平均较治疗前降低(P<0.05),且研究组低于对照组(P< 0.05)。治疗后,2组血清TNF-α、CRP、IL-6水平均较治疗前降低(P<0.05),且研究组3项指标水平均低于 对照组(P<0.05)。治疗后,2组VEGF、bFGF水平均较治疗前降低(P<0.05),且研究组VEGF、bFGF水平 均低于对照组(P<0.05)。结论:宁嗽化痰汤治疗COPD急性加重期患者疗效显著,可有效缓解临床症状,改 善肺功能及肺部血管功能,减轻机体炎症反应,从而改善气道重塑。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of Ningsou Huatan Decoction in the treatment of acute exacerbation of chronic obstructive pulmonary disease (COPD) and its effects on serum levels of inflammatory factors,vascular endothelial growth factor (VEGF),and basic fibroblast growth factor (bFGF). Methods:A total of 126 patients with acute exacerbation of COPD hospitalized at Jinhua Hospital of Traditional Chinese Medicine from January 2022 to December 2023 were enrolled. They were randomly divided into the control group and the study group using the random number table method,with 63 cases in each group. The control group received conventional western medicine treatment,while the study group received Ningsou Huatan Decoction in addition to the treatment given to the control group. Both groups were treated for two weeks. The clinical efficacy, traditional Chinese medicine syndrome scores,pulmonary function indices [forced expiratory volume in one second (FEV1),forced vital capacity (FVC),FEV1/FVC value],blood gas analysis indices [arterial partial pressure of oxygen (PaO2),arterial partial pressure of carbon dioxide (PaCO2)], inflammatory factor levels [interleukin-6 (IL-6), C-reactive protein (CRP),tumor necrosis factor-α (TNF-α)],and levels of VEGF and bFGF were compared before and after treatment. Results: After treatment, the total effective rate was 95.24% (60/63) in the study group and 79.37% (50/63) in the control group,with a statistically significant difference between the two groups (P<0.05). After treatment, the scores for dyspnea, cough, wheezing, expectoration, and the total traditional Chinese medicine syndrome score decreased in both groups compared to before treatment (P<0.05), and all scores were lower in the study group than in the control group (P<0.05). After treatment,the levels of FEV1,FVC,and FEV1/ FVC increased in both groups compared to before treatment (P<0.05), and all levels of the three indices were higher in the study group than in the control group (P<0.05). After treatment,PaO2 levels increased in both groups compared to before treatment (P<0.05),and were higher in the study group than in the control group (P<0.05). PaCO2 levels decreased in both groups compared to before treatment (P<0.05),and were lower in the study group than in the control group (P<0.05). After treatment,serum levels of TNF-α,CRP,and IL-6 decreased in both groups compared to before treatment (P<0.05),and all levels of the three indices were lower in the study group than in the control group (P<0.05). After treatment, the levels of VEGF and bFGF decreased in both groups compared to before treatment (P<0.05),and were lower in the study group than in the control group (P<0.05). Conclusion:Ningsou Huatan Decoction is significantly effective in the treatment of patients with acute exacerbation of COPD. It can effectively relieve clinical symptoms,improve pulmonary function and pulmonary vascular function, reduce systemic inflammatory responses,so as to ameliorate airway remodeling.

    参考文献
    相似文献
    引证文献
引用本文

赵晨充,何绿苑,林文波,李朗.宁嗽化痰汤治疗慢性阻塞性肺疾病急性加重期疗效观察及对血清炎症因子、VEGF 及bFGF 水平的影响[J].新中医,2026,58(8):42-47

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-04-29
  • 出版日期:
文章二维码